# CHT105 for the Treatment of Refractory Lupus Nephritis

> **NCT07517536** · NA · NOT_YET_RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 14 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus
- Lupus Nephritis

## Interventions

- **BIOLOGICAL:** anti-CD19/70 CAR T cells (CHT105)

## Key facts

- **NCT ID:** NCT07517536
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-01
- **Final completion:** 2028-01
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07517536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07517536, "CHT105 for the Treatment of Refractory Lupus Nephritis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT07517536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*